Reduction of lipoprotein(a) with proprotein convertase subtilisin/kexin type 9 inhibitor as a potential contributor to modulating coronary inflammatory activity: insights from serial pericoronary adipose tissue analysis

被引：2
|
作者：
Kitahara, Satoshi [1 ]
Kataoka, Yu [1 ]
Miura, Hiroyuki [1 ]
Noguchi, Teruo [1 ]
机构：
[1] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan
来源：
EUROPEAN HEART JOURNAL | 2022年 / 43卷 / 16期
关键词：
D O I：
10.1093/eurheartj/ehab882
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1597 / 1597
页数：1
相关论文
共 50 条
  • [31] Prenylated Flavonoids from the Roots and Rhizomes of Sophora tonkinensis and Their Effects on the Expression of Inflammatory Mediators and Proprotein Convertase Subtilisin/Kexin Type 9
    Ahn, Jongmin
    Kim, Young-Mi
    Chae, Hee-Sung
    Choi, Young Hee
    Ahn, Hee-Chul
    Yoo, Hunseung
    Karig, Minseok
    Kim, Jinwoong
    Chin, Young-Won
    JOURNAL OF NATURAL PRODUCTS, 2019, 82 (02): : 309 - 317
  • [32] A stilbene dimer and flavonoids from the aerial parts of Chromolaena odorata with proprotein convertase subtilisin/kexin type 9 expression inhibitory activity
    Pel, Pisey
    Chae, Hee-Sung
    Nhoek, Piseth
    Kim, Young-Mi
    Khiev, Piseth
    Kim, Geum Jin
    Nam, Joo-Won
    Choi, Hyukjae
    Choi, Young Hee
    Chin, Young-Won
    BIOORGANIC CHEMISTRY, 2020, 99
  • [33] Can proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors regress coronary atherosclerotic plaque? A systematic review and meta-analysis
    Wu, Zijia
    Gao, Lulan
    Lin, Zhihai
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2023, 15 (01): : 452 - 465
  • [34] Persistent arterial wall inflammation in patients with elevated lipoprotein(a) despite strong low-density lipoprotein cholesterol reduction by proprotein convertase subtilisin/kexin type 9 antibody treatment
    Stiekema, Lotte C. A.
    Stroes, Erik S. G.
    Verweij, Simone L.
    Kassahun, Helina
    Chen, Lisa
    Wasserman, Scott M.
    Sabatine, Marc S.
    Mani, Venkatesh
    Fayad, Zahi A.
    EUROPEAN HEART JOURNAL, 2019, 40 (33) : 2775 - +
  • [35] Applicability and Cost Implications for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Based on the ODYSSEY Outcomes Trial: Insights From the Department of Veterans Affairs
    Virani, Salim S.
    Akeroyd, Julia M.
    Nambi, Vijay
    Michos, Erin D.
    Morris, Pamela B.
    Nasir, Khurram
    Smith, Sidney C., Jr.
    Stone, Neil J.
    Petersen, Laura A.
    Ballantyne, Christie M.
    CIRCULATION, 2019, 139 (03) : 410 - 412
  • [36] Chemical Constituents with Proprotein Convertase Subtilisin/Kexin Type 9 mRNA Expression Inhibitory Activity from Dried Immature Morus alba Fruits
    Pel, Pisey
    Chae, Hee-Sung
    Nhoek, Piseth
    Kim, Young-Mi
    Chin, Young-Won
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2017, 65 (26) : 5316 - 5321
  • [37] Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Patients Following Acute Coronary Syndromes: From Lipid Lowering and Plaque Stabilization to Improved Outcomes
    Dimitriadis, Kyriakos
    Pyrpyris, Nikolaos
    Iliakis, Panagiotis
    Beneki, Eirini
    Adamopoulou, Eleni
    Papanikolaou, Aggelos
    Konstantinidis, Dimitrios
    Fragkoulis, Christos
    Kollias, Anastasios
    Aznaouridis, Konstantinos
    Tsioufis, Konstantinos
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (17)
  • [38] Impact of early initiation of proprotein convertase subtilisin/kexin type 9 inhibitors in patients with acute coronary syndrome: A systematic review meta-analysis
    Nagendra, Lakshmi
    Mahajan, Kunal
    Gupta, Gunjan
    Dutta, Deep
    INDIAN HEART JOURNAL, 2023, 75 (06) : 416 - 422
  • [39] POLYMORPHIC ASSESSMENT OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) VARIANT RS11591147 IN CORONARY ARTERY DISEASE SUBJECTS FROM PAKISTAN
    Shabana, D.
    Shahid, S. U.
    ATHEROSCLEROSIS, 2022, 355 : E190 - E190
  • [40] Early administration of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors in patients with acute coronary syndrome: a systematic review and meta-analysis
    Hosseini, Kaveh
    Soleimani, Hamidreza
    Maleki, Saba
    Nasrollahizadeh, Amir
    Tayebi, Sima
    Nelson, John
    Heffron, Sean P.
    BMC CARDIOVASCULAR DISORDERS, 2024, 24 (01):
12345